These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Kimura Y; Sumiyoshi M Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337 [TBL] [Abstract][Full Text] [Related]
24. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis. Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240 [TBL] [Abstract][Full Text] [Related]
25. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis. Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194 [TBL] [Abstract][Full Text] [Related]
26. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway. Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522 [TBL] [Abstract][Full Text] [Related]
27. The β Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069 [TBL] [Abstract][Full Text] [Related]
28. Curcumin inhibits lymphangiogenesis in vitro and in vivo. Wang W; Sukamtoh E; Xiao H; Zhang G Mol Nutr Food Res; 2015 Dec; 59(12):2345-54. PubMed ID: 26375757 [TBL] [Abstract][Full Text] [Related]
29. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Shin JW; Huggenberger R; Detmar M Blood; 2008 Sep; 112(6):2318-26. PubMed ID: 18614759 [TBL] [Abstract][Full Text] [Related]
30. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer. Wang J; Ma Y; Yang J; Jin L; Gao Z; Xue L; Hou L; Sui L; Liu J; Zou X J Cell Mol Med; 2019 Mar; 23(3):2219-2229. PubMed ID: 30648805 [TBL] [Abstract][Full Text] [Related]
31. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway. Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the activity and the mechanism of action of a new toluquinol derivative with improved potential as an antiangiogenic drug. Torres-Vargas JA; Cheng-Sánchez I; Martínez-Poveda B; Medina MÁ; Sarabia F; García-Caballero M; Quesada AR Biomed Pharmacother; 2022 Nov; 155():113759. PubMed ID: 36271548 [TBL] [Abstract][Full Text] [Related]
33. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Krebs R; Tikkanen JM; Ropponen JO; Jeltsch M; Jokinen JJ; Ylä-Herttuala S; Nykänen AI; Lemström KB Am J Pathol; 2012 Nov; 181(5):1607-20. PubMed ID: 22959907 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer. Shi J; Li YJ; Yan B; Wei PK Oncol Rep; 2015 Jun; 33(6):2703-10. PubMed ID: 25891418 [TBL] [Abstract][Full Text] [Related]
35. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183 [TBL] [Abstract][Full Text] [Related]
36. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756 [TBL] [Abstract][Full Text] [Related]
37. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. Goldman J; Rutkowski JM; Shields JD; Pasquier MC; Cui Y; Schmökel HG; Willey S; Hicklin DJ; Pytowski B; Swartz MA FASEB J; 2007 Apr; 21(4):1003-12. PubMed ID: 17210781 [TBL] [Abstract][Full Text] [Related]
38. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling. Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404 [No Abstract] [Full Text] [Related]
39. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047 [TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis. Coso S; Zeng Y; Opeskin K; Williams ED PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]